Hong Kong · Delayed Price · Currency is HKD Jiangsu Hengrui Medicine Company Description
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally.
The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents.
It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products.
Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.
| Country | China |
| Founded | 1970 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 20,238 |
| CEO | Ji Feng |
Contact Details
Address: No. 38, Huanghe Road Lianyungang City, Liaoning Province 222000 China | |
| Phone | 86 40 0828 3900 |
| Website | hengrui.com |
Stock Details
| Ticker Symbol | 1276 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Piao Yang Sun | Executive Chairman of the Board |
| Hong Bin Dai | Executive Deputy Chairman of the Board |
| Kin Chun Lau | Chief Financial Officer |
| Jie Ping Sun | Senior Vice President and Executive Director |
| Dr. Lian Shan Zhang Ph.D. | Executive Vice President and Executive Director |
| Dr. Ningjun Jiang M.D., Ph.D. | Executive Vice President, Chief Strategy Officer and Executive Director |
| Xiao Han Liu | Board Secretary |
| Ya Ping Shen | Deputy General Manager |
| Cheng Liao | Deputy General Manager |
| Feng He | Deputy General Manager |